Author:
Mohammad Amad,Hor Mosab,Baradeiya Ahmed M,Qasim Hodan,Nasr Mohamed
Reference28 articles.
1. Ovarian cancer;Arora T,2022
2. A phase I, single-arm, open-label, dose escalation study of intraperitoneal cisplatin and doxorubicin in patients with recurrent ovarian cancer and peritoneal carcinomatosis;Tempfer CB;Gynecol Oncol,2018
3. Pressurized intraperitoneal aerosol chemotherapy for recurrent ovarian, fallopian or primary peritoneal cancer with peritoneal carcinomatosis: a narrative review;Oh S;Gland Surg,2021
4. Pressurised intraperitoneal aerosol chemotherapy: rationale, evidence, and potential indications;Alyami M;Lancet Oncol,2019
5. The emergence of pressurized intraperitoneal aerosol chemotherapy as a palliative treatment option for patients with diffuse peritoneal metastases: a narrative review;Lurvink RJ;J Gastrointest Oncol,2021